Narwhal Medical is developing a catheter-based blood pump that is the smallest and most deliverable on the market, designed to enhance patient mobility during cardiac procedures. This technology addresses the limitations of traditional blood pumps, which can be cumbersome and restrict patient movement.
Funding
Funding not disclosed
Founders
Product
Problem
Current percutaneous ventricular assist devices (pVADs) have large delivery profiles, which can exclude a significant number of patients from receiving necessary circulatory support. These large profiles are also associated with higher rates of access site complications.
Solution
Narwhal Medical is developing a miniaturized, catheter-based blood pump designed to be the smallest and most deliverable pVAD on the market. This technology aims to increase the number of patients eligible for circulatory support by reducing the delivery profile. The smaller profile is also intended to decrease access site complications, potentially leading to decreased recovery times and procedural costs.
Target Audience
The primary target audience includes high-risk patients requiring circulatory support and medical professionals specializing in cardiac procedures.
Features
- Catheter-based design for percutaneous delivery
- Miniaturized pump size to reduce delivery profile
- Designed to increase patient eligibility for pVAD therapy
- Aims to decrease access site complications associated with larger devices